The global anti-ageing drugs market is showing the significant growth; mainly due to increase in ageing population, growing demand for anti-aging drugs, and influence of media and fashion industry.
As per World Health Organization (WHO) estimates, by 2020, the number of people aged 60 years and older will outnumber children younger than 5 years and by 2050, 80% of older people will be living in low- and middle-income countries.Companies are showing much interest toward the anti-aging drugs market, as they feels there are huge opportunity and gap between the market demand and supply of effective treatments.
The development has been made by Johnson & Johnson in 2016, when they announced the acquisition of NeoStrata Company, Inc., for getting the global leadership and deliver advanced skin care drugs to consumers around the world.
These acquisition will leads to innovation in better way and help them to compete there competitor with more effective manner.
Johnson & Johnson try to feel the gap along with market players such as GlaxoSmithKline plc (U.K), Johnson & Johnson, Nu Skin, Novartis AG, RGP Life Sciences, The Estée Lauder Companies Inc., Bayer Pharma AG, L'Oréal S.A., Elysium Health InGet Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3504 Competitive Analysis:Some of the major companies in the global anti-aging services market include Allergan Inc., Alma Lasers, Beiersdorf AG, Cutera Inc., Cynosure Inc., Elizabeth Arden, Estee Lauder Inc., Lumenis, Procter & Gamble, Solta Medical Inc.Segmentation:The anti-aging services market is segmented on type of service, service provider, and region.
Additionally, the better results are estimated to remain as a trend in coming years, which is likely to benefit the market growth.